Tci Gene (ROCO:6879) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6879 Tci Gene Inc ROCO:6879
65 GF Score
Price NT$36.65
GF Value NT$48.98
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Tci Gene Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Tci Gene's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

ROCO:6879 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, Tci Gene's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Tci Gene's Margin of Safety % (DCF Dividends Based) falls into.


ROCO:6879
65GF Score
Tci Gene Inc ROCO:6879
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tci Gene (ROCO:6879) Overvalued in 2026?

Based on GuruFocus' analysis, Tci Gene stock appears to be undervalued. The current stock price of NT$36.65 is trading 25.2% below its estimated GF Value™ of NT$48.98. GuruFocus considers Tci Gene to be Modestly Undervalued.

Key valuation signals for ROCO:6879:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: NT$48.98 vs. price of NT$36.65 (25.2% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tci Gene Business Description

Address No. 185-1, Gangqian Road, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.
65GF Score

Get the complete analysis for ROCO:6879

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$36.65
Price
NT$48.98
GF Value